Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
NCT ID: NCT04351893
Last Updated: 2024-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
935 participants
OBSERVATIONAL
2018-02-23
2023-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Otological Study of Facial Cleft Patients Over 10 Years of Age (Excluding Isolated Cleft Lip) (EFEOF)
NCT06738927
Microbiologic Findings of Acute Facial Palsy in Children
NCT01537952
Community Pediatric Acceptability Study (CPAS)
NCT02610699
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
NCT04611516
Comparing MRI to CT on Pediatric Craniosynostosis.
NCT04704284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant with CFM is 0-18 years of age
* Participant has diagnosis of at least one of the following conditions:
* Microtia
* Anotia
* Facial asymmetry AND preauricular tag(s)
* Facial asymmetry AND facial tag(s)
* Facial asymmetry AND epibulbar dermoid
* Facial asymmetry AND macrostomia (i.e., lateral cleft)
* Preauricular tag AND epibulbar dermoid
* Preauricular tag AND macrostomia
* Facial Tag AND epibulbar dermoid
* Macrostomia AND epibulbar dermoid
* Participant's parent or legal guardian has provided written informed consent prior to enrollment into study (for participants younger than 18 years of age).
* Participant speaks a language in which they are eligible for consent at their enrolling site
Parents:
* Parent participant is the biological parent of a case participant already eligible and participating in the CAUSE study. Non-genetic parents will be interviewed about their child's known prenatal and genetic family history but will not be asked to provide DNA or have facial photographs taken.
* Participant speaks a language in which they are eligible for consent at their enrolling site
Other relatives:
* Other relatives participants, of any age, are related biologically to a case participant already eligible and participating in the CAUSE study from a multiplex family (multiple affected individuals with CFM).
* Participant speaks a language in which they are eligible for consent at their enrolling site
EXCLUSION:
Cases:
* Participant is diagnosed with a known syndrome that involves microtia and underdevelopment of the jaw (Townes-Brocks, Treacher-Collins, Branchiootorenal, Nager, or Miller syndromes).
* Participant has abnormal chromosome studies (karyotype).
* Participant has mandibular asymmetry due to deformational plagiocephaly or torticollis.
0 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Los Angeles
OTHER
Children's Hospital of Philadelphia
OTHER
University of North Carolina, Chapel Hill
OTHER
Pontificia Universidad Javeriana
OTHER
Universidad Icesi
OTHER
Hospital Nacional Edgardo Rebagliati Martins
OTHER
Instituto de Investigación Hospital Universitario La Paz
OTHER
Clinica Comfamiliar Risaralda
UNKNOWN
Seattle Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carrie Heike
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carrie Heike, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Seattle Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Los Angeles
Los Angeles, California, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Seattle Children's Hospital
Seattle, Washington, United States
Pontificia Universidad Javeriana
Bogotá, , Colombia
ICESI
Cali, , Colombia
Pontificia Universidad Javeriana
Cali, , Colombia
Clínica Comfamiliar Risaralda
Pereira, , Colombia
Hospital Edgardo Rebagliati Martins
Lima, , Peru
Instituto de Genética Médica y Molecular (INGEMM)
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-601-E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.